Publication | Agea | Males (%) | No infection PSPa ng/ml | Infection PSPa ng/ml | No infection CRPa mg/l | Infection CRPa mg/l | No infection PCTa ng/ml | Infection PCTa ng/ml |
---|---|---|---|---|---|---|---|---|
Keel et al. [14] | 35 [21.5, 50.5] | 48 (76%) | 19.58 [12.79, 28.96] | 52 [18.98, 170.5] | 102 [70.5, 128.75] | 113 [62, 162] | 0.38 [0.25, 0.54] | 0.54 0.34, 1.2] |
Llewelyn [15] | 66 [53, 75] | 108 (60%) | 17.8 [11.7, 29.7] | 107.75 [49.08, 247] | 10.6 [3.4, 26.5] | 144.65 [104.97, 203.05] | 0.2 [0.1, 0.8] | 3.1 [0.8, 8.83] |
Gukasjan et al. [17] | 61 [50, 71] | 75 (55%) | 15.2 [11.21, 23.24] | 125.25 [25.73, 414.38] | 51.3 [32.7, 86.4] | 222.8 [144.25, 286.55] | 0.1 [0.03, 0.2] | 1.07 [0.28, 6.05] |
Klein et al. [18] | 67 [54, 75] | # | 22.6 [13.77, 46.7] | 51.68 [33.18, 76.4] | 125 [92.25, 157.75] | 132.5 [106.25, 188.75] | # | # |
Guadiana-Romualdo et al. [13] | 65.5 [46.75, 78.25] | 89 (59%) | 22.7 [17.2, 30.35] | 73 [33.2, 203] | 48 [19, 135] | 130 [67, 210] | 0.08 [0.06, 0.15] | 0.54 [0.23, 2.45] |